A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum β-lactamases

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 3, 2007, Pages 387-395

  Ensor, Vicki M ^a,b   Livermore, D M ^c   Hawkey, P M ^a,b  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

ESBLs; Genotyping; Molecular epidemiology; Multiplex PCR

Indexed keywords

BACTERIAL DNA; BACTERIAL ENZYME; EXTENDED SPECTRUM BETA LACTAMASE; EXTENDED SPECTRUM BETA LACTAMASE CTX M; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; BETA LACTAMASE; BETA LACTAMASE CTX M 14; BETA LACTAMASE CTX M 15; BETA-LACTAMASE CTX-M-14; BETA-LACTAMASE CTX-M-15;

AMPLICON; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA SEQUENCE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; MOLECULAR EPIDEMIOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; OPEN READING FRAME; PHYLOGENY; VALIDATION PROCESS; GENETICS; METHODOLOGY; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION;

BETA-LACTAMASES; GENOTYPE; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION;

EID: 34248219092     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl505     Document Type: Article

References (33)

1. Livermore DM, Woodford N. The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 2006; 14: 413-20.
2. Livermore DM, Hawkey PM. CTX-M: Changing the face of ESBLs in the UK. J Antimicrob Chemother 2005; 56: 451-4.
3. Bonnet R. Growing group of extended-spectrum β-lactamases: The CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
4. Woodford N, Ward ME, Kaufmann ME et. al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735-43.
5. Pitout JD, Nordmann P, Laupland KB et al. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005; 56: 52-9.
6. Shibata N, Kurokawa H, Doi Y et al. PCR classification of CTX-M-type β-lactamase genes identified in clinicaly isolated gram-negative bacilli in Japan. Antimicrob Agents Chemother 2006; 50: 791-5.
7. CTX-M genes by multiplex PCR assay. J Med Microbiol 2005; 54: 1183-7.
8. Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J Antimicrob Chemother 2006; 57: 154-5.
9. Chia JH, Chu C, Su LH et al. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M β-lactamases of Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae in Taiwan. J Clin Microbiol 2005; 43: 4486-91.
10. Birkett CI, Ludlam HA, Woodford N et al. A real-time TaqMan PCR method for the detection and characterisation of CTX-M genotypes in extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae In: Abstracts of the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 2005. American Society For Microbiology, Washington, DC. USA.
11. Morcillo N, Zumarraga M, Alto A et al. A low cost, home-made, reverse-line blot hybridisation assay for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2002; 6: 959-65.
12. Potz NA, Hope R, Warner M et al. Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England. J Antimicrob Chemother 2006; 58: 320-6.
13. Ensor V, Mandozana J, Kumari P et al. Detection and molecular characterisation of CTX-M-type extended-spectrum β-lactamases from faeces and blood culture samples. In: Abstracts of the Health Protection Agency Annual Scientific Conference, University of Warwick, 2006. Health Protection Agency, London, UK.
14. Ensor VM, Shahid M, Evans JT et al. Occurrence, prevalence and genetic environment of CTX-M β-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 2006; 58: 1260-3.
15. Ambler RP, Coulson AF, Frere JM et al. A standard numbering scheme for the class A β-lactamases. Biochem J 1991; 276: 269-70.
16. Mugnaioli C, Luzzaro F, De Luca F et al. CTX-M-type extended-spectrum β-lactamases in Italy: Molecular epidemiology of an emerging countrywide problem. Antimicrob Agents Chemother 2006; 50: 2700-6.
17. Radice M, Power P, Di Conza J et al. Early dissemination of CTX-M-derived enzymes in South America. Antimicrob Agents Chemother 2002; 46: 602-4.
18. Chmelnitsky I, Carmeli Y, Leavitt A et al. CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum β-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel. Antimicrob Agents Chemother 2005; 49: 4745-50.
19. Baraniak A, Fiett J, Sulikowska A et al. Countrywide spread of CTX-M-3 extended-spectrum β-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother 2002; 46: 151-9.
20. Coque TM, Oliver A, Perez-Diaz JC et al. Genes encoding TEM-4 SHV-2, and CTX-M-10 extended-spectrum β-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob Agents Chemother 2002; 46 500-10.
21. Brinas L, Lantero M, de Diego I et al. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital. J Antimicrob Chemother 2005; 56: 1107-10.
22. Wang H, Kelkar S, Wu W et al. Clinical isolates of Enterobacteriaceae producing extended-spectrum β-lactamases: Prevalence of CTX-M-3 at a hospital in China. Antimicrob Agents Chemother 2003; 47: 790-3.
23. Yu Y, Ji S, Chen Y et al. Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China. J Infect doi:10.1016/j.jinf.2006.01.014
24. Kim J, Lim YM, Rheem I et al. CTX-M and SHV-12 β-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol Lett 2005; 245: 93-8.
25. Yu WL, Cheng KC, Wu LT, Pfaller MA, Winokur PL, Jones RN. Emergence of two Klebsiella pneumoniae isolates harboring plasmid-mediated CTX-M-15 β-lactamase in Taiwan. Antimicrob Agents Chemother 2004; 48: 362-63.
26. Boyd DA, Tyler S, Christianson S et al. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum β-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004; 48: 3758-64.
27. Conceicao T, Brizio A, Duarte A et al. First description of CTX-M-15-producing Klebsiella pneumoniae in Portugal. Antimicrob Agents Chemother 2005; 49: 477-8.
28. Damjanova I, Toth A, Paszti J et al. Nationwide spread of clonally related CTX-M-15-producing multidrug-resistant Klebsiella pneumoniae strains in Hungary. Eur J Clin Microbiol Infect Dis 2006; 25 275-8.
29. Lartigue MF, Poirel L, Heritier C et al. First description of CTX-M-15-producing Klebsiella pneumoniae in Turkey. J Antimicrob Chemother 2003; 52: 315-16.
30. Valenzuela de Silva EM, Mantilla Anaya JR, Reguero Reza MT et al. Detection of CTX-M-1, CTX-M-15, and CTX-M-2 in clinical isolates of Enterobacteriaceae in Bogota, Colombia. J Clin Microbiol 2006; 44: 1919-20.
31. Markovska R, Schneider I, Keuleyan E et al. Extended-spectrum β-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria. Clin Microbiol Infect 2004; 10: 752-5.
32. Soge OO, Queenan AM, Ojo KK et al. CTX-M-15 extended-spectrum β-lactamase from Nigerian Klebsiella pneumoniae. J Antimicrob Chemother 2006; 57: 24-30.
33. Sonnevend A, Al Dhaheri K, Mag T et al. CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates. Clin Microbiol Infect 2006; 12: 582-5.